Adnin Ashrafi

Adnin Ashrafi

Auto-generated profile, based on publicly available information

Adnin Ashrafi

University of Texas at Dallas, Richardson, TX

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
TWTianyuan Wang
Tianyuan Wang
AAAdnin Ashrafi
Adnin Ashrafi
PKPurna Chaitanya Konduri
Purna Chaitanya Konduri
PGPoorva Ghosh
Poorva Ghosh
SDSanchareeka Dey
Sanchareeka Dey
Li ZhangLi Zhang
Li Zhang
Heme is an essential nutritional, metabolic, and signaling molecule in living organisms. Pathogenic microbes extract heme from hosts to obtain metallonutrient, while heme fuels mitochondrial respiration and ATP generation in lung tumor cells. Here, we generated small heme-sequestering proteins (HeSPs) based on bacterial hemophores. These HeSPs contain neutral mutations in the heme-binding pocket and hybrid sequences from hemophores of different bacteria. We showed that HeSPs bind to heme and effectively extracted heme from hemoglobin. They strongly inhibited heme uptake and cell proliferation and induced apoptosis in non–small cell lung cancer (NSCLC) cells, while their effects on nontumorigenic cell lines representing normal lung cells were not significant. HeSPs strongly suppressed the growth of human NSCLC tumor xenografts in mice. HeSPs decreased oxygen consumption rates and ATP levels in tumor cells isolated from treated mice, while they did not affect liver and blood cell functions. IHC, along with data from Western blotting and functional assays, revealed that HeSPs reduced the levels of key proteins involved in heme uptake, as well as the consumption of major fuels for tumor cells, glucose, and glutamine. Further, we found that HeSPs reduced the levels of angiogenic and vascular markers, as well as vessel density in tumor tissues. Together, these results demonstrate that HeSPs act via multiple mechanisms, including the inhibition of oxidative phosphorylation, to suppress tumor growth and progression. Evidently, heme sequestration can be a powerful strategy for suppressing lung tumors and likely drug-resistant tumors that rely on oxidative phosphorylation for survival.

1 January 2022 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
SDSanchareeka Dey
Sanchareeka Dey
AAAdnin Ashrafi
Adnin Ashrafi
CVChantal Vidal
Chantal Vidal
NJNivesh Jain
Nivesh Jain
SKSarada Preeta Kalainayakan
Sarada Preeta Kalainayakan
Li ZhangLi Zhang
Li Zhang
Lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC) are two most common subtypes of lung cancer. Here, to identify new, targetable molecular properties of both subtypes, we monitored changes in the levels of heme- and oxidative phosphorylation (OXPHOS)-related proteins during lung tumorigenesis. Heme is a central molecule for oxidative metabolism and ATP generation via OXPHOS. Notably, both lung ADC and SCC tumors can be induced in the genetically engineered KLLuc mouse model harboring the G12D Kras mutation and a conditional Lkb1 knockout. We found that the levels of the rate-limiting heme synthesis enzyme ALAS1 and uptake protein SLC48A1, along with OXPHOS complex subunits, progressively increased as lung tumorigenesis advanced. Our data demonstrated that elevated levels of heme- and OXPHOS-related proteins were associated with both ADC and SCC. Importantly, treatment of KLLuc mice with a heme-sequestering protein, HeSP2, that inhibits heme uptake in tumor cells effectively arrested lung tumor progression, and both ADC and SCC tumors were strongly suppressed. Additionally, HeSP2 effectively suppressed the growth of both SCC and ADC tumor xenografts in NOD/SCID mice. Further analyses indicated that HeSP2 effectively diminished OXPHOS in both ADC and SCC, reduced angiogenesis, alleviated tumor hypoxia, and suppressed cell proliferation. These results show that the advancing of lung tumorigenesis requires progressive increase in cellular heme synthesis and uptake, leading to intensified OXPHOS activity and ATP generation and promoting aggressive tumorigenic functions. Implications: Heme sequestration is an effective strategy for the suppression of both ADC and SCC tumor initiation and development.

3 April 2023
Verified
Other
Open access
TWTianyuan Wang
Tianyuan Wang
AAAdnin Ashrafi
Adnin Ashrafi
PKPurna Chaitanya Konduri
Purna Chaitanya Konduri
PGPoorva Ghosh
Poorva Ghosh
SDSanchareeka Dey
Sanchareeka Dey
Li ZhangLi Zhang
Li Zhang

3 April 2023
Verified
Other
Open access
TWTianyuan Wang
Tianyuan Wang
AAAdnin Ashrafi
Adnin Ashrafi
PKPurna Chaitanya Konduri
Purna Chaitanya Konduri
PGPoorva Ghosh
Poorva Ghosh
SDSanchareeka Dey
Sanchareeka Dey
Li ZhangLi Zhang
Li Zhang
Figure S5. HeSP treatment effectively inhibits transporters and key enzymes in glucose and glutamine metabolism in subcutaneous NSCLC tumor xenografts. A, Representative montage and 10X IHC images of H1299 NSCLC tumor tissue sections and graphs showing the levels of SLC2A1 in control and HeSP-treated tumors. B, Representative montage and 10X IHC images of H1299 NSCLC tumor tissue sections and graphs showing the levels of HK2 in control and HeSP-treated tumors. C, Representative montage and 10X IHC images of H1299 NSCLC tumor tissue sections and graphs showing the levels of SLC1A5 in control and HeSP-treated tumors. D, Representative montage and 10X IHC images of H1299 NSCLC tumor tissue sections and graphs showing the levels of GLS in control and HeSP-treated tumors. Shown are montages and 10X images of control and HeSP-treated tumor tissue sections stained with DAPI (row 1) or antibodies against the indicated protein (row 2) or merged images of DAPI and the indicated protein (row 3). The white rectangles in DAPI images denote the regions shown in 10X images. Scale bar, montage, 1 mm; 10X, 200 μm. Protein levels were quantified, and data were plotted as mean {plus minus} SEM. ***, P < 0.005.

3 April 2023
Verified
Other
Open access
SDSanchareeka Dey
Sanchareeka Dey
AAAdnin Ashrafi
Adnin Ashrafi
CVChantal Vidal
Chantal Vidal
NJNivesh Jain
Nivesh Jain
SKSarada Preeta Kalainayakan
Sarada Preeta Kalainayakan
Li ZhangLi Zhang
Li Zhang
Supplementary Figure 1. The levels of proteins and enzyme subunits involved in OXPHOS and glutamine metabolism increase with lung tumor progression. A, Representative H&E and IHC images of lung tissue sections from KLLuc mice showing levels of the OXPHOS protein HCCS. B, Representative H&E and IHC images of lung tissue sections from KLLuc mice showing levels of the glutamine transporter SLC1A5. C, Representative H&E and IHC images of lung tissue sections from KLLuc mice showing levels of GLS. Shown are montage images of lung tissue sections stained with H&E (row 1), montage images stained with DAPI (row 2) or antibodies against the indicated protein (row 3), and 10X images of lung tissue sections stained with DAPI (row 4) or antibodies against the indicated protein (row 5). The light green lines in DAPI montage images outline the tumors in the lung. The blue rectangles in H&E and white rectangles in DAPI montage images denote the regions shown in 10X. Scale bar, montage, 1mm; 4X, 200 µm; 10X, 100µm. D, Graph showing quantified levels of HCCS correlating with A. E, Graph showing quantified levels of SLC1A5 correlating with B. F, Graph showing quantified levels of GLS correlating with C. Protein levels were quantified, and data are plotted as mean {plus minus} SEM. G, Representative 40X IHC images of lung tissue sections showing the co-localization of ATP5F1A, COX7B, and CYCS with the mitochondrial marker TOMM20. Scale bar, 10 µm. H, OCR of NSCLC H226 cells cultured in normal medium, or heme depleted medium with 0.5 mM succinyl acetone (HD+SA). Heme (5 µM, 10 µM, and 20 µM, respectively) was added back to examine the effects of heme on OCRs. For statistical analysis, the levels in cells with heme added back were compared with the levels in cells without heme added back with a Welch two-sample t test. **, P<0.005.

3 April 2023
Verified
Other
Open access
TWTianyuan Wang
Tianyuan Wang
AAAdnin Ashrafi
Adnin Ashrafi
PKPurna Chaitanya Konduri
Purna Chaitanya Konduri
PGPoorva Ghosh
Poorva Ghosh
SDSanchareeka Dey
Sanchareeka Dey
Li ZhangLi Zhang
Li Zhang
Figure S3. HeSPs effectively suppress the growth, oxygen consumption rates (OCRs), and ATP generation in subcutaneous A549-luc NSCLC tumor xenografts and HeSPs do not cause significant toxic effects on mouse liver and blood. A, Photos showing excised tumors from NOD/SCID mice treated with saline (control) or HeSPs (25 mg/kg I.V. every 3 days) for 3 weeks (n = 5/group). B, Average masses for control and treated tumors shown. C, The time course of tumor volumes in control and mice treated with HeSPs. Tumor volumes were calculated weekly using Caliper measurements and are shown here. D, Average body masses of control and treated mice bearing tumors. E, Oxygen consumption rates (OCRs) measured in cells from control and treated tumors. F, ATP levels measured in cells from control and treated tumors. G, Average serum ALT (alanine transaminase) levels in mice bearing subcutaneous lung tumor xenografts treated with or without HeSPs. H, Relative liver ATP levels in live cells from mice bearing subcutaneous lung tumor xenografts treated with or without HeSPs. I, Average red blood cell counts in mice bearing subcutaneous lung tumor xenografts treated with or without HeSPs. J, Average hemoglobin levels in mice bearing subcutaneous lung tumor xenografts treated with or without HeSPs. Data were plotted as mean {plus minus} SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.005.